Hexaware Applied sciences Restricted, a world digital and expertise providers firm, is arising with its Preliminary Public Providing (IPO) in February 2025. This text gives upcoming IPO and assessment of Hexaware Applied sciences IPO, overlaying firm particulars, aggressive strengths, financials, challenge particulars, dangers, evaluation and whether or not buyers ought to subscribe or keep away from this IPO.
Additionally Learn: Upcoming IPO Ajax Engg IPO Opens on Feb 10 – Is that this good or unhealthy?
About Hexaware Applied sciences Restricted
Included in 1992, Hexaware Applied sciences is a world IT and digital options firm that leverages synthetic intelligence (AI) to drive digital transformation. The corporate affords providers throughout a number of industries, together with banking, monetary providers, insurance coverage, healthcare, manufacturing, and shopper providers.
Hexaware has a robust international presence with 39 supply facilities and 16 workplaces throughout the Americas, Europe, and Asia-Pacific. The corporate has vital offshore supply capabilities in India (Chennai, Pune, Bengaluru, Noida) and Sri Lanka, with plans to increase into Tier 2 cities like Ahmedabad.
Aggressive Strengths
- AI-powered digital options: The corporate gives superior automation and cloud options by means of its platforms like RapidX™, Tensai®, and Amaze®.
- Numerous international clientele: Hexaware serves blue-chip clients throughout industries, making certain secure income streams.
- Skilled management staff: The administration staff has in depth expertise within the IT and digital transformation trade.
- Robust monetary efficiency: Constant income progress and profitability, with excessive return on web value (RoNW).
Hexaware Applied sciences IPO Particulars
- IPO Opening Date: February 12, 2025
- IPO Closing Date: February 14, 2025
- Allotment Date: February 17, 2025
- Itemizing Date: February 19, 2025
- Concern Dimension: ₹8,750 Crores
- Concern Kind: Supply for Sale (OFS)
- IPO Value Band: ₹674 – ₹708 per share
- Lot Dimension: 21 Shares
- Minimal Funding: ₹14,868 (for retail buyers)
- Itemizing Exchanges: BSE & NSE
- Lead Managers: Kotak Mahindra Capital, Citigroup, J.P. Morgan, HSBC Securities, IIFL Securities
- Registrar: KFin Applied sciences Restricted
Why Hexaware Applied sciences Delisted shares earlier?
You is likely to be questioning that Hexaware Applied sciences Shares had been already listed and traded earlier, then how come it’s arising with IPO now.
Firm shared had been listed until Nov-2020. It bought delisted from the bourses in November 2020 after the corporate’s then promoters had accepted the found delisting worth of ₹ 475 per share
Financials of Hexaware Applied sciences Restricted (₹ in Crores)
Interval Ending | Income | Web Revenue | Web Value |
---|---|---|---|
9M FY 2024 | 8,871.3 | 853.3 | 4,876 |
31-Dec-2023 | 10,389.1 | 997.6 | 4,230.9 |
31-Dec-2022 | 9,378.8 | 884.2 | 3,778.1 |
31-Dec-2021 | 7,244.6 | 748.8 | 3,503.7 |
Hexaware has demonstrated regular income progress and profitability, making it a financially sturdy firm.
Objects of the IPO
Since this can be a full Supply for Sale (OFS), the corporate is not going to obtain any proceeds from the IPO. The promoting shareholder, CA Magnum Holdings (Promoter), goals to dump its stake by means of this providing.
Hexaware Applied sciences IPO Valuation – P/E Ratio In comparison with Friends
Firm | P/E Ratio |
---|---|
Hexaware Applied sciences | 41x |
Persistent Techniques | 84x (Highest) |
Mphasis | 34x (Lowest) |
Business Common | 55x |
Hexaware’s P/E of 41x is absolutely priced..
Causes to Spend money on Hexaware Applied sciences IPO
- Robust Market Place – Hexaware is a well-established IT providers firm with a robust consumer base.
- Constant Development – The corporate has proven regular monetary progress lately.
- World Enlargement Plans – Plans to enter Tier 2 cities in India and increase supply facilities may drive future progress.
- AI and Cloud Focus – The corporate’s funding in AI-driven options offers it a aggressive edge.
Threat Elements to Think about
- Premium Valuation – The IPO is priced at a P/E of 41x in comparison with rivals like Infosys, Wipro and others that are buying and selling beneath 25x.
- No Contemporary Concern – Because the IPO is solely an OFS, Hexaware is not going to obtain any capital for growth.
- IT Sector Slowdown – Any slowdown within the IT trade may influence income progress.
- Excessive Dependence on Giant Purchasers – Lack of key purchasers may have an effect on monetary efficiency.
Hexaware Applied sciences IPO Gray Market Premium (GMP)
As of now, the GMP for Hexaware Applied sciences IPO is ₹ 19 to ₹ 42 per share. This means reasonable demand within the gray market.
- GMP as per Chittorgarh – ₹ 19 per share
- GMP as per IPOWatch – ₹ 20 per share
- GMP as per Investorgain – ₹ 19 per share
- Nonetheless AliceBlue says Hexaware Tech IPO GMP at ₹ 46
(Word: GMP fluctuates and will change nearer to the itemizing date.)
Methods to Apply for Hexaware Applied sciences IPO?
- By means of ASBA (Web Banking): Login to your financial institution’s web banking portal, navigate to IPO part, and apply utilizing ASBA.
- Utilizing UPI (Brokers/Buying and selling Apps): Apply by means of on-line buying and selling apps like Zerodha, Groww, Upstox, and so on., by linking your UPI ID.
Chances are you’ll like: Methods to faucet Pre-IPO Shares for hidden Alternatives?
Hexaware Applied sciences IPO Assessment – Ought to You Make investments?
Hexaware Applied sciences is a well-established IT providers firm with a robust monitor report. Nonetheless, the IPO is absolutely priced in comparison with its friends, and because it’s an OFS, the corporate is not going to obtain any funds for progress.
Who ought to make investments?
- Traders with a long-term perspective who imagine in Hexaware’s AI and cloud-driven progress story.
- These snug with reasonable to excessive valuations.
Who ought to keep away from?
- Traders on the lookout for fast itemizing positive factors, because the premium pricing might restrict upside potential.
- These preferring IPOs with a recent challenge part to assist growth.
Closing Verdict: Impartial to Optimistic – Appropriate for long-term buyers, however might not get itemizing positive factors as a consequence of reasonable to excessive valuation in IPO Value and low GMP.
Do you intend to use for Hexaware Applied sciences IPO? Share your ideas within the feedback beneath!
Disclaimer: This text is for academic functions solely. Investing in IPOs or Shares is riskier, and you might lose your capital. Please seek the advice of your monetary advisor earlier than investing in IPOs

Uncover extra from Myinvestmentideas.com
Subscribe to get the newest posts despatched to your e-mail.